Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 2019

View Archived Issues

Mouse model of 8-OH-DPAT-induced compulsive-like responses confirms the key role of 5-HT

EA-230 attenuates the systemic inflammatory response in humans

Chromatin problem linked to accelerated aging

CD40-targeting peptide KGYY-6 may ameliorate multiple sclerosis

Tuberculosis vaccine MTBVAC shows promise in phase I/II trial in adults and infants

New potent vanin-1 inhibitor as preclinical candidate for inflammatory bowel disease

FDA grants approval for Taltz as treatment of active ankylosing spondylitis

Positive topline results from pivotal phase III ORION-11 study of inclisiran

PACAP27 identified as a novel target for the treatment of migraine

IL-2-R336A fusion toxin enhances antitumor immune response in preclinical models

Esteve Pharmaceuticals describes dual CACNA2D1/mu opioid receptor ligands

New lysosomal acid glucosylceramidase inhibitors identified at Takeda

Heparegenix synthesizes new MAPKK 4 inhibitors

Janssen presents respiratory syncytial virus replication inhibitors

Ubiquitin carboxyl-terminal hydrolase 19 inhibitors discovered at Almac Discovery

Ivy, Salarius Pharmaceuticals enter collaboration to develop new cancer treatment for glioblastoma

DNA's sweet tooth linked to increased cancer risk with diabetes

Basilea completes enrollment in phase I study of oral BAL-101553 in brain cancer

New global phase IIa study evaluates tezepelumab for moderate to very severe COPD

Phase IIb CONDUCT study of cobitolimod in ulcerative colitis meets primary endpoint

ADC Therapeutics and Freenome enter biomarker collaboration for ADCT-402 program

CPRIT grant supports Emtora's development of eRapa for familial adenomatous polyposis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...